92 related articles for article (PubMed ID: 7725484)
1. Severe recurrence of type I membranoproliferative glomerulonephritis after transplantation: remission on steroids and cyclophosphamide.
Cahen R; Trolliet P; Dijoud F; Megri K; François B
Transplant Proc; 1995 Apr; 27(2):1746-7. PubMed ID: 7725484
[No Abstract] [Full Text] [Related]
2. Recurrent type I membranoproliferative glomerulonephritis after renal transplantation and protective role of cyclosporine in acute crescentic transformation.
Ahsan N; Manning EC; Dabbs DJ; Gifford RR; Yang HC
Clin Transplant; 1997 Feb; 11(1):9-14. PubMed ID: 9067687
[TBL] [Abstract][Full Text] [Related]
3. The incidence of membranoproliferative glomerulonephritis in renal allografts.
Moritz MJ; Burke JF; Jarrell BE; Carabasi RA
Transplant Proc; 1987 Feb; 19(1 Pt 3):2206-7. PubMed ID: 3274492
[No Abstract] [Full Text] [Related]
4. A case of IgA nephritis showing diffuse podocytic detachment from the glomerular basement membrane.
Moriya T; Nakazawa K; Itoh N; Shigematsu H; Higuchi M; Miyasaka M; Oguchi H
Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):423-30. PubMed ID: 1635288
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine in the treatment of membranoproliferative glomerulonephritis.
Bagheri N; Nemati E; Rahbar K; Nobakht A; Einollahi B; Taheri S
Arch Iran Med; 2008 Jan; 11(1):26-9. PubMed ID: 18154419
[TBL] [Abstract][Full Text] [Related]
6. Decrease of mesangial matrix after immunosuppressive therapy in children with reversible membranoproliferative glomerulonephritis type I.
Inaba S; Tanizawa T; Takahashi T; Ishihara S; Arai M; Sakai Y; Kurose KK; Matsukura H; Okada T
Clin Nephrol; 1996 Apr; 45(4):217-25. PubMed ID: 8861795
[TBL] [Abstract][Full Text] [Related]
7. A 65-year-old man with early renal allograft dysfunction.
Hill PA; Crikis S; Goodman DG
Am J Kidney Dis; 2003 Jul; 42(1):207-11. PubMed ID: 12830474
[No Abstract] [Full Text] [Related]
8. Recurrence of membranoproliferative glomerulonephritis in renal allografts.
Shimizu T; Tanabe K; Oshima T; Tokumoto T; Okuda H; Ishikawa N; Toma H
Transplant Proc; 1998 Nov; 30(7):3910-3. PubMed ID: 9838711
[No Abstract] [Full Text] [Related]
9. Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
Kawasaki Y; Hosoya M; Takahashi A; Isome M; Tanji M; Suzuki H
Am J Kidney Dis; 2005 Mar; 45(3):510-8. PubMed ID: 15754273
[TBL] [Abstract][Full Text] [Related]
10. [Effect of ligustrazine on proliferative glomerulonephritis].
Tang X
Zhong Yao Cai; 2003 Aug; 26(8):611-2. PubMed ID: 14649206
[TBL] [Abstract][Full Text] [Related]
11. Severe fibrin and crescent glomerulonephritis: clinical and morphological aspects of 33 patients.
Mathew TH; Kincaid-Smith P
Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):727-34. PubMed ID: 4803314
[No Abstract] [Full Text] [Related]
12. Treatment-resistant recurrent membranoproliferative glomerulonephritis in renal allograft responding to rituximab: case report.
Farooqui M; Alsaad K; Aloudah N; Alhamdan H
Transplant Proc; 2015 Apr; 47(3):823-6. PubMed ID: 25891740
[TBL] [Abstract][Full Text] [Related]
13. Steroid resistance in prolonged type I membranoproliferative glomerulonephritis and accelerated disease remission after steroid withdrawal.
Kazama I; Matsubara M; Ejima Y; Michimata M; Suzuki M; Miyama N; Sato A; Sato H; Ito S
Clin Exp Nephrol; 2005 Mar; 9(1):62-8. PubMed ID: 15830276
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of IgM nephropathy in a renal allograft.
Salmon AH; Kamel D; Mathieson PW
Nephrol Dial Transplant; 2004 Oct; 19(10):2650-2. PubMed ID: 15388823
[No Abstract] [Full Text] [Related]
15. Long-term follow-up of type III membranoproliferative glomerulonephritis in children.
Iitaka K; Moriya S; Nakamura S; Tomonaga K; Sakai T
Pediatr Nephrol; 2002 May; 17(5):373-8. PubMed ID: 12042898
[TBL] [Abstract][Full Text] [Related]
16. Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases.
Masutani K; Katafuchi R; Ikeda H; Yamamoto H; Motoyama K; Sugitani A; Kanai H; Kumagai H; Hirakata H; Tanaka M; Iida M
Clin Transplant; 2005; 19 Suppl 14():59-64. PubMed ID: 15955171
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of type II membranoproliferative glomerulonephritis in two children.
Iitaka K; Nakamura S; Moriya S; Koshino H; Iwasaki N; Motoyama O; Sakai T
Clin Exp Nephrol; 2003 Mar; 7(1):58-62. PubMed ID: 14586745
[TBL] [Abstract][Full Text] [Related]
18. Effect of acetylsalicylic acid and dipyridamole in primary membranoproliferative glomerulonephritis type I.
Harmankaya O; Baştürk T; Oztürk Y; Karabiber N; Obek A
Int Urol Nephrol; 2001; 33(3):583-7. PubMed ID: 12230299
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience.
Braun MC; Stablein DM; Hamiwka LA; Bell L; Bartosh SM; Strife CF
J Am Soc Nephrol; 2005 Jul; 16(7):2225-33. PubMed ID: 15888559
[TBL] [Abstract][Full Text] [Related]
20. Type of immune and complement deposits and response of immunosuppressive treatment on Membranoproliferative Glomerulonephritis -- a single centre experience.
Imtiaz S; Dhrolia MF; Nasir K; Salman B; Ahmad A
J Pak Med Assoc; 2015 Sep; 65(9):995-1000. PubMed ID: 26338748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
